Updates: Whatever Happened to Drugs from Goats? Mar 7, 2009
based GTC Biotherapeutics. The goats generate the human protein antithrombin, which inhibits clotting. (Scientific American)
Lundbeck Rises After Takeover Adds Foothold in US Feb 10, 2009
Ovation also has rights to sell an intravenous therapy known as ATryn, a blood-clot prevention that is purified from the milk of goats whose parents were injected with a human protein developed by GTC Biotherapeutics Inc.. Lundbeck retained Deutsche Bank AG as financial adviser and Morgan, Lewis & Bockius for legal advice. (Bloomberg)
1st Drug From Genetically Altered Animals Approved Feb 10, 2009
GTC Biotherapeutics said federal regulators approved its drug, ATryn, which includes milk from goats that have been genetically altered to produce an extra protein that acts as a natural blood thinner, the Associated Press reported. The drug will be used to treat the estimated one in 5,000 people with a rare genetic disorder -- hereditary antithrombin deficiency -- that leads to a lack of the protein, leaving them vulnerable to potentially deadly blood clots, the news service said. (U.S. News & World Report)
FDA OKs 1st drug from genetically altered animals Feb 9, 2009
GTC Biotherapeutics said regulators cleared its drug ATryn, which is manufactured using milk from goats that have been scientifically altered to produce extra antithrombin, a protein that acts as a natural blood thinner. The drug's approval may be the first step toward new kinds of medications made not from chemicals, but from living organisms altered by scientists. (Yahoo News)
FDA approves medicine from engineered goats Feb 8, 2009
Made by GTC Biotherapeutics, the drug is produced by a herd of 200 goats that live under quarantine on a high-security farm in central Massachusetts ... GTC Biotherapeutics said one of its goats can produce as much antithrombin in a year as can be derived from 90,000 blood donations. (International Herald Tribune)
Fresh from the farm, a biotech 'milestone' Feb 7, 2009
Goats at GTC Biotherapeutics' farm are driven from barn to barn to keep them from catching diseases. (Suzanne Kreiter/Globe Staff/File 2006) By Globe Staff / February 7, 2009. (Boston Globe)
